• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

New editor at IOVS

Article

David Beebe, PhD, FARVO, has been elected as the editor-in-chief of Investigative Ophthalmology & Visual Science (IOVS), the journal of the Association for Research in Vision and Ophthalmology (ARVO).

Rockville, MD-David Beebe, PhD, FARVO, has been elected as the editor-in-chief of Investigative Ophthalmology & Visual Science (IOVS), the journal of the Association for Research in Vision and Ophthalmology (ARVO).

Beebe was elected by ARVO’s members to replace current IOVS editor-in-chief Paul L. Kaufman, MD. Beebe’s 5-year term will begin in January 2013, and he will serve as editor-in-chief for 5 years. A former ARVO Trustee, Beebe served as the association’s president from 2000 to 2001.

Beebe is the Janet and Bernard Becker professor of ophthalmology and visual sciences at Washington University in St. Louis, MO. From 1998 to 2007, he served as an editorial board member of IOVS, and currently is an associate editor of the journal, managing manuscripts dealing with lens and cataract, eye development, cell biology, and all genetic studies of eye diseases. Beebe was also a member of the editorial board of Experimental Eye Research for 6 years.

The journal is online only (www.iovs.org) and articles are published daily.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.